Is curing multiple sclerosis possible and how is a "cure" defined? CURE-MS is a study aimed at answering these questions and reaching consensus. CURE-MS is a modified Delphi panel study using a multistakeholder approach, which includes MS neurologists, patients, patient advocates and industry representatives.
CURE-MS wants to hear from you! 👉
redcap.uza.be/studies/survey…
⏰ The survey takes no more than 15 minutes. The pre-Delphi round is open until 31 May 2026.
The steering committee of CURE-MS is comprised of:
• Antonia Lefter, University of Antwerp, Belgium, University of Oxford, UK
• Georgina Arrambide, CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Hospital Universitari Vall d'Hebron, Spain
• Yolanda Blanco, Hospital Clínic de Barcelona, Spain
• Radu Tanasescu, Nottingham University Hospitals, UK
• Hélène Zéphir, CHU de Lille, France
• Paola Zaratin, Italian MS Society Foundation, Italy
• Barbara Willekens, UZA and University of Antwerp, Belgium
All data collection and management related to this survey are handled solely by the initiative organisers. ECTRIMS is not responsible for the management of data collected through partner initiatives.
#MSStudy #CUREMS #MSResearch #MS #MultipleSclerosis